Amplatzer Piccolo Occluder clinical trial for percutaneous closure of the patent ductus arteriosus in patients ≥700 grams

OBJECTIVES: Characterize the safety and effectiveness of the Amplatzer Piccolo Occluder for patent ductus arteriosus (PDA) closure. BACKGROUND: The presence of a hemodynamically significant PDA has been associated with an increased risk of morbidity and mortality in children born premature. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Sathanandam, Shyam K., Gutfinger, Dan, O'Brien, Laura, Forbes, Thomas J., Gillespie, Matthew J., Berman, Darren P., Armstrong, Aimee K., Shahanavaz, Shabana, Jones, Thomas K., Morray, Brian H., Rockefeller, Toby A., Justino, Henri, Nykanen, David G., Zahn, Evan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
PEDIATRIC AND CONGENITAL HEART DISEASE
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754477/
https://www.ncbi.nlm.nih.gov/pubmed/32433821
http://dx.doi.org/10.1002/ccd.28973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754477/
https://www.ncbi.nlm.nih.gov/pubmed/32433821
http://dx.doi.org/10.1002/ccd.28973

Ejemplares similares